Experience

AzurRx BioPharma, Inc.

• President AzurRX SAS

  • Oct 2008 - Jun 2019

  AzurRx SAS (formerly ProteaBio Europe) founded in 2008 by Stephen Turner and Daniel Dupret is since 2014 a wholly-owned subsidiary of the US biotech public company AzurRx BioPharma. AzurRx develops new therapeutic biologics for human health, focusing on non-systemic biologics combining early and advanced stage of development products. Non-systemic biologics are non-absorbable drugs that act locally without reaching the systemic circulation, i.e. the intestinal lumen, skin or mucosa.



Proteus SA

• France
• Research Services

• President & CEO; Founder

  • Jun 1998 - Jan 2007

  Région de Nîmes, France Protéus is an internationally recognized biotech company that designs, improves and produces protein-based products for three distinct markets:  Novel Proteins for industrial needs, through exclusive partnership with companies such as Degussa, Syngenta, Veolia, Firmenich, etc.  APIs (Advanced Pharmaceutical Ingredients) and pharmaceutical intermediates. This market is addressed through PCAS Biosolution, a joint-venture between Protéus and the European fine chemical company… Show more Protéus is an internationally recognized biotech company that designs, improves and produces protein-based products for three distinct markets:  Novel Proteins for industrial needs, through exclusive partnership with companies such as Degussa, Syngenta, Veolia, Firmenich, etc.  APIs (Advanced Pharmaceutical Ingredients) and pharmaceutical intermediates. This market is addressed through PCAS Biosolution, a joint-venture between Protéus and the European fine chemical company PCAS  Protein manufacturing and engineering for the pharmaceutical industry. This market is addressed by a dedicated business unit, PSI (Protéus Services for Industry). 80% of the Protéus activity is done on an international basis Show less



Appligene SA

• India
• Consumer Services

• President and CEO; Founder

  • 1985 - 1998

  Appligène was engineering, manufacturing and selling reagents and instruments for the medical research and diagnose. In 1995, Appligène had 75 employees, offices in US, Germany, UK and commercial distribution partnership all over Europe and in China. Appligène customers were academic research laboratories, industrial companies as well as public and private medical diagnose laboratories.



Transgene

• France
• Biotechnology
• 100 - 200 Employee

• Chef de groupe

  • 1982 - 1985

  Région de Strasbourg, France Clonage et production de protéines thérapeutiques